Propacetamol is a prodrug form of paracetamol which is formed from esterification of paracetamol, and the carboxylic acid Diethylglycin. This has the advantage of making it more water soluble. It is used in post-operative care and is delivered by I.V..[2] It is given if the patient is unable to take oral or rectally delivered paracetamol and non-steroidal anti-inflammatory drugs are contraindicated. The onset of analgaesia from propacetamol is more rapid than paracetamol given orally.[3] 2g of propacetamol are equivalent to 1g of paracetamol.[4]
[edit] See also
[edit] References
- ^ a b Bannwarth B, Netter P, Lapicque F, Gillet P, Péré P, Boccard E, Royer RJ, Gaucher A (1992). "Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol". Br J Clin Pharmacol 34 (1): 79–81. PMC 1381380. PMID 1633071. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1381380.
- ^ a b Binhas M, Decailliot F, Rezaiguia-Delclaux S, Suen P, Dumerat M, François V, Combes X, Duvaldestin P (2004). "Comparative effect of intraoperative propacetamol versus placebo on morphine consumption after elective reduction mammoplasty under remifentanil-based anesthesia: a randomized control trial [ISRCTN71723173"]. BMC Anesthesiol 4: 6. doi:10.1186/1471-2253-4-6. PMC 520811. PMID 15367329. http://www.biomedcentral.com/1471-2253/4/6. Retrieved 2008-04-01.
- ^ Moller PL, Sindet-Pedersen S, Petersen CT, Juhl GI, Dillenschneider A, Skoglund LA (2005). "Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery". Br J Anaesth 94 (5): 642–8. doi:10.1093/bja/aei109. PMID 15790675. http://bja.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=15790675. Retrieved 2008-04-04.
- ^ Flouvat B, Leneveu A, Fitoussi S, Delhotal-Landes B, Gendron A (2004). "Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects". Int J Clin Pharmacol Ther 42 (1): 50–7. PMID 14756388.
|
|
|
| Phytocannabinoids |
|
|
| Cannabinoid metabolites |
|
|
| Endogenous cannabinoids |
|
|
Synthetic cannabinoid
receptor agonists |
Classical cannabinoids
(Dibenzopyrans) |
|
|
| Nonclassical cannabinoids |
|
|
| Benzoylindoles |
|
|
| Naphthoylindoles |
|
|
| Naphthylmethylindoles |
|
|
| Phenylacetylindoles |
|
|
| Naphthoylpyrroles |
|
|
| Eicosanoids |
|
|
| Others |
|
|
|
Allosteric modulators of
cannabinoid receptors |
|
|
Endocannabinoid
activity enhancers |
|
|
Cannabinoid receptor
antagonists and
inverse agonists |
|
|